AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27703344
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose (HD) of Fluticasone 1,000 μg/day
Trial: 12868184
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg once daily for 30 days
Trial: 12868184
Drug: Fenofibrate 200
RxNorm normalized name: fenofibrate 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 200 mg once daily for 30 days
Trial: 10372724
Drug: Calcium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium infusion (1.1 mg calcium gluconate/cc in 5% dextrose at a rate of 4 cc/kg x h) (n = 7)
Trial: 10372724
Drug: Human PTH-(1-34)
RxNorm normalized name: PTH
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Human PTH-(1-34) infusion (0.55 U/kg x h) (n = 9)
Trial: 8501265
Drug: Baclofen as
RxNorm normalized name: Baclofen
DrugBank: Baclofen (DB00181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baclofen as protective therapy
Trial: 3123603
Drug: L‐deprenyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐deprenyl
Trial: 29752998
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein group (HP) - 35 g of protein after training sessions
Trial: 29752998
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein group (LP) - 35 g of placebo after training sessions
Trial: 22691263
Drug: NOP‐47 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NOP‐47 (5 g)
Trial: 7925334
Drug: sufentanil 2
RxNorm normalized name: SUFentanil 250 MCG in 5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sufentanil 2 micrograms ml‐1 (5 micrograms h‐1) in 0.167% bupivacaine
Trial: 7925334
Drug: sufentanil 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sufentanil 4 micrograms ml‐1 (10 micrograms h‐1) in 0.167% bupivacaine
Trial: 7925334
Drug: sufentanil 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sufentanil 4 micrograms ml‐1 (10 micrograms h‐1) in normal saline
Trial: 1190685
Drug: Postoperative intraperitoneal
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative intraperitoneal lavage with antibiotics
Trial: 1190685
Drug: Postoperative drainage
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative drainage without lavage, systemic antibiotics
Trial: 27168463
Drug: Flurbiprofen (FP)
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (FP) patch
Trial: 23233136
Drug: lidocaine +
RxNorm normalized name: Lidocaine + Menthol Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lidocaine + metoclopramide (10 mg)
Trial: 23233136
Drug: lidocaine +
RxNorm normalized name: Lidocaine + Menthol Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lidocaine + ketamine (5 mg)
Trial: 23233136
Drug: lidocaine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lidocaine (20 mg)
Trial: 3881242
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg once daily
Trial: 9100593
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human IGF-I (rhIGF-I) therapy (80 micrograms.kg.day)
Trial: 8112546
Drug: Upper gastrointestinal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Upper gastrointestinal endoscopy with sedation using i.v. midazolam at a dosage of 0.05 mg/kg
Trial: 3595668
Drug: Adriamycin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adriamycin (20 mg/week)
Trial: 27225729
Drug: Dairy yogurt
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dairy yogurt supplemented with rhamnogalacturonan (RG) - 150 mL daily containing 50 mg of probiotics and 100 mg of hallabong peel polysaccharide (60% RG) for 8 weeks
Trial: 27225729
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group - same product without hallabong peel supplement for 8 weeks
Trial: 21748368
Drug: 6% CHO-E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% CHO-E solution
Trial: 21748368
Drug: 2% CHO-E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% CHO-E solution
Trial: 21748368
Drug: 10% CHO-E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% CHO-E solution
Trial: 12422579
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate 400 mg + clarithromycin 500 mg + amoxycillin 1000 mg (RBCCA)
Trial: 12422579
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate 400 mg + clarithromycin 500 mg + metronidazole 500 mg (RBCCM)
Trial: 12422579
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + clarithromycin 500 mg + amoxycillin 1000 mg (OCA)
Trial: 12422579
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + clarithromycin 500 mg + metronidazole 500 mg (OCM)
Trial: 9122012
Drug: Immunosuppressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive treatment in group I (61 patients with glomerular disease at diagnosis)
Trial: 9122012
Drug: Immunosuppressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive treatment in group II (24 patients with restrained disease activity)
Trial: 9122012
Drug: Immunosuppressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive treatment in group III (14 patients with active glomerulopathy)
Trial: 9122012
Drug: Urinary excretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary excretion of IC
Trial: 9122012
Drug: Simultaneous excretion
RxNorm normalized name: gonorrheal urethral secretion human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous excretion of C4 in urine
Trial: 1745621
Drug: 500-mg ETA
RxNorm normalized name: .MU.-METHYLENE-.MU.-CHLOROBIS(.ETA.5-2,4-CYCLOPENTADIEN-1-YL)(DIMETHYLALUMINUM)TITANIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500-mg ETA suppository
Trial: 1745621
Drug: 250-mg ETA
RxNorm normalized name: .MU.-METHYLENE-.MU.-CHLOROBIS(.ETA.5-2,4-CYCLOPENTADIEN-1-YL)(DIMETHYLALUMINUM)TITANIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250-mg ETA tablets
Trial: 1745621
Drug: Two placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two placebo tablets
Trial: 7035987
Drug: Propranolol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (320 mg given in 8 doses over a period of 24 hours)
Trial: 30684965
Drug: Curcumin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin plus placebo (CC)
Trial: 30684965
Drug: Curcumin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin plus long-chain omega-3 polyunsaturated fatty acids (CC-FO)
Trial: 28320856
Drug: Baroreflex activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baroreflex activation therapy
Trial: 17228169
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with standardized, aluminum hydroxide‐adsorbed J. ashei extract (100 IR, 54 microg of Jun a 1/ml)
Trial: 8646573
Drug: Dye laser
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dye laser treatment
Trial: 3434348
Drug: Chloramphenicol treatment
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol treatment continued after negative cultures
Trial: 3434348
Drug: Chloramphenicol treatment
RxNorm normalized name: Chloramphenicol
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol treatment withdrawn after negative cultures
Trial: 27792719
Drug: Surgical debridement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical debridement and topical application of silver sulfadiazine (SSD)
Trial: 25523578
Drug: Dexamethasone (DXM)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DXM) treatment for 1 week
Trial: 25523578
Drug: Dexamethasone (DXM)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DXM) treatment for 2 weeks
Trial: 22646167
Drug: CAO +
RxNorm normalized name: Gan Cao Root
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAO + S (simvastatin 20 mg)
Trial: 20621700
Drug: Standard duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard duration therapy (24 weeks)
Trial: 20621700
Drug: Variable duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Variable duration therapy (VD12 for 12 weeks and VD24 for 24 weeks)
Trial: 20621700
Drug: Variable duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Variable duration therapy (VD12 for 12 weeks)
Trial: 20621700
Drug: Variable duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Variable duration therapy (VD24 for 24 weeks)
Trial: 17826201
Drug: Active TSE
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active TSE treatment
Trial: 17826201
Drug: Sham TSE
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham TSE treatment
Trial: 17826201
Drug: Active and
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active and Sham TSE treatments
Trial: 10578484
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (350 mg)
Trial: 10578484
Drug: RRR-alpha-tocopherol (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRR-alpha-tocopherol (250 mg)
Trial: 10578484
Drug: Beta-carotene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (60 mg)
Trial: 10578484
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (350 mg) + RRR-alpha-tocopherol (250 mg)
Trial: 8722735
Drug: Patient-controlled morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled morphine consumption (mg)
Trial: 1914760
Drug: Cimetidine (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (800 mg by mouth 2 hr before the start)
Trial: 6350957
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g of ornidazole
Trial: 6350957
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g of ornidazole
Trial: 6350957
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g of ornidazole
Trial: 28270284
Drug: Saline flush
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline flush at 3.0 ml/s (40 ml) - Group A
Trial: 28270284
Drug: Saline flush
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline flush at 4.0 ml/s (40 ml) - Group B
Trial: 26846324
Drug: DHA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA supplementation (50 mg/day)
Trial: 17674476
Drug: Combined antiviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined antiviral therapy (CAT)
Trial: 25675557
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment (control group)
Trial: 8942410
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (7.2 g per day)
Trial: 1916166
Drug: Per-rectal pulsed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Per-rectal pulsed irrigation
Trial: 1916166
Drug: Per-oral colonic
RxNorm normalized name: Sus scrofa colon preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Per-oral colonic lavage
Trial: 6345426
Drug: Conalbumin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conalbumin plus traditional dietetic therapy
Trial: 6345426
Drug: Traditional dietetic
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional dietetic therapy
Trial: 24716847
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone gel 300 mcg/day
Trial: 27628323
Drug: JE-CV booster
RxNorm normalized name: Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated Injectable Suspension [Je-Vax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JE-CV booster dose
Trial: 18194330
Drug: 5000 ppm
RxNorm normalized name: Sodium Fluoride 5000 PPM
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5000 ppm F-toothpaste used twice a day
Trial: 18194330
Drug: 1450 ppm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1450 ppm F-toothpaste used twice a day
Trial: 17663803
Drug: Dietary portfolio
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary portfolio high in plant sterols (1 g/4200 kJ), soya proteins (21.4 g/4200 kJ), soluble fibres (9.8 g/4200 kJ) and almonds (14 g/4200 kJ)
Trial: 16398595
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg lovastatin
Trial: 1524078
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 250 mg twice daily (n = 157)
Trial: 1524078
Drug: Amoxicillin/clavulanate 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 500 mg three times daily (n = 160)
Trial: 1524078
Drug: Amoxicillin/clavulanate 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 500 mg three times daily
Trial: 6406442
Drug: Bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (150 or 450 mg/day)
Trial: 6406442
Drug: Imipramine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (up to 200 mg/day)
Trial: 29912913
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules containing Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14
Trial: 17676423
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA (5.2 g daily)
Trial: 9673809
Drug: S-fluoxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-fluoxetine
Trial: 8033434
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous immune globulin (IVIG)
Trial: 2917360
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg 4-OHA orally once, twice, and 4 times daily for 2 weeks
Trial: 2917360
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg i.m. every 2 weeks
Trial: 2917360
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg 4-OHA orally 4 times daily
Trial: 2917360
Drug: Parenteral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral treatment
Trial: 23685080
Drug: Traction with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traction with a 500 mL weighted bag
Trial: 17302684
Drug: Antiarrhythmic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic therapy (preferably amiodarone)
Trial: 11173143
Drug: Conformal radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conformal radiotherapy with dose escalation
Trial: 9744780
Drug: Weekly 5‐FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly 5‐FU 600 mg/m2 i.v. bolus (30 patients)
Trial: 9744780
Drug: Weekly 5‐FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly 5‐FU 600 mg/m2 bolus plus leucovorin (LV) 500 mg/m2 2‐h i.v. infusion (28 patients)
Trial: 9744780
Drug: Weekly 5‐FU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly 5‐FU 2600 mg/m2 24‐h continuous i.v. infusion plus LV 100 mg 4‐h i.v. infusion and 50 mg orally every 4 h for five doses (24 patients)
Trial: 31377776
Drug: Aspirin or
RxNorm normalized name: aspirin Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin or transoesophageal echocardiogram prior to cardioversion
Trial: 31377776
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral anticoagulation or transoesophageal echocardiogram prior to cardioversion
Trial: 31377776
Drug: Aspirin or
RxNorm normalized name: aspirin Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin or aspirin plus clopidogrel
Trial: 606768
Drug: Intramuscular vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccination (200 chick cell-agglutinating units/0.5-ml dose)
Trial: 606768
Drug: Intradermal vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal vaccination (40 chick cell-agglutinating units/0.1-ml dose)
Trial: 30989788
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution of misoprostol (Cytotec®)
Trial: 28623755
Drug: Adjunctive lacosamide
RxNorm normalized name: Lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjunctive lacosamide (LCM)
Trial: 28623755
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (≥2 AEDs with stable dosing)
Trial: 26308294
Drug: Hydrocortisone 50
RxNorm normalized name: hydrocortisone 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 50 mg twice daily for 1 week
Trial: 26308294
Drug: Placebo 50
RxNorm normalized name: placebo 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 50 mg twice daily for 1 week
Trial: 18648227
Drug: Sugammadex 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 16 mg/kg administered 3 min after 1.0 mg/kg rocuronium
Trial: 18648227
Drug: Sugammadex 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 16 mg/kg administered 15 min after 1.0 mg/kg rocuronium
Trial: 18648227
Drug: Sugammadex 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 16 mg/kg administered 3 min after 1.2 mg/kg rocuronium
Trial: 18648227
Drug: Sugammadex 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 16 mg/kg administered 15 min after 1.2 mg/kg rocuronium
Trial: 9262298
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (LDA) 50 mg/day
Trial: 9336321
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine (100 mg)
Trial: 8371143
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine (100 mg) with alcohol (1 g/kg)
Trial: 8371143
Drug: Alcohol alone
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol alone (1 g/kg)
Trial: 27461846
Drug: Tedizolid phosphate
RxNorm normalized name: Tedizolid Phosphate
DrugBank: Tedizolid (DB14569)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tedizolid phosphate 200 mg IV
Trial: 28865799
Drug: Tedizolid phosphate
RxNorm normalized name: Tedizolid Phosphate
DrugBank: Tedizolid (DB14569)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tedizolid phosphate 200 mg PO
Trial: 27461846
Drug: Tedizolid phosphate
RxNorm normalized name: Tedizolid Phosphate
DrugBank: Tedizolid (DB14569)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tedizolid phosphate 200 mg (multiple dosing)
Trial: 27461846
Drug: Tedizolid phosphate
RxNorm normalized name: Tedizolid Phosphate
DrugBank: Tedizolid (DB14569)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tedizolid phosphate 200 mg
Trial: 25402495
Drug: Zirconium cyclosilicate
RxNorm normalized name: ZIRCONIUM CYCLOSILICATE ION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zirconium cyclosilicate 5 g daily for 28 days
Trial: 25402495
Drug: Zirconium cyclosilicate
RxNorm normalized name: ZIRCONIUM CYCLOSILICATE ION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zirconium cyclosilicate 10 g daily for 28 days